ConductScience.org, home

Paper6500548

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.

Clark WH and 5 others. Hum Pathol, 1984. Cited by 832 papers, by iCite.

Cite this record

ConductScience Library. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Papers, record 6500548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6500548

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
PubMed
Journal
Hum Pathol
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
832
iCite
Relative citation ratio, by iCite
20.1
iCite
Revised in PubMed
2019-07-22
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clark WH JrW H
2Elder DED E
3Guerry D 4thD
4Epstein MNM N
5Greene MHM H
6Van Horn MM

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Nevus, PigmentedMajor topic
Skin NeoplasmsMajor topic
Adolescent
Adult
Cell Transformation, Neoplastic
Child
Child, Preschool
Female
Humans
Hyperplasia
Male
Melanocytes
Middle Aged
Neoplasm Invasiveness
Neoplasm Metastasis
Schwann Cells
Skin
Time Factors

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-1650NCI NIH HHSUnited StatesPubMedPubMed
CA-25298NCI NIH HHSUnited StatesR01CA025298PubMed and NIHNIH RePORTER
CA-26655NCI NIH HHSUnited StatesR01CA026655PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by190

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 832 citations.

PMIDTitleJournalYearIn PapersSource
42773192[The dysplastic nevus].Pathologie (Heidelb)2026https://conductscience.org/library/papers/42773192PubMed
41845929Hypothyroidism as Prognostic Factor in Cutaneous Melanoma: A 1553-Patient Single-Center Study.Cancer Med2026https://conductscience.org/library/papers/41845929PubMed
41752154Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions.Int J Mol Sci2026https://conductscience.org/library/papers/41752154PubMed
41023436Highly multiplexed 3D profiling of cell states and immune niches in human tumors.Nat Methods2025https://conductscience.org/library/papers/41023436PubMed
40941017Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge.Cancers (Basel)2025https://conductscience.org/library/papers/40941017PubMed
40900523Local Recurrence and Survival in Patients With Melanoma In Situ.JAMA Dermatol2025https://conductscience.org/library/papers/40900523PubMed
40686544Tumor-infiltrating lymphocytes in melanoma: diagnostic and prognostic implications from biopsy to circulation.J Liq Biopsy2025https://conductscience.org/library/papers/40686544PubMed
39489491Melanoma Diagnosis in the Mihm Era-And Beyond.J Cutan Pathol2026https://conductscience.org/library/papers/39489491PubMed
39212334Splicing control by PHF5A is crucial for melanoma cell survival.Cell Prolif2025https://conductscience.org/library/papers/39212334PubMed
39201498Contribution of Keratinocytes in Skin Cancer Initiation and Progression.Int J Mol Sci2024https://conductscience.org/library/papers/39201498PubMed
38396984Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR.Int J Mol Sci2024https://conductscience.org/library/papers/38396984PubMed
38254769PRAME Is an Effective Tool for the Diagnosis of Nevus-Associated Cutaneous Melanoma.Cancers (Basel)2024https://conductscience.org/library/papers/38254769PubMed
37835902DermAI 1.0: A Robust, Generalized, and Novel Attention-Enabled Ensemble-Based Transfer Learning Paradigm for Multiclass Classification of Skin Lesion Images.Diagnostics (Basel)2023https://conductscience.org/library/papers/37835902PubMed
37426410Identification of sterile a-motif domain-containing 9-like as a potential biomarker in patients with cutaneous melanoma.PeerJ2023https://conductscience.org/library/papers/37426410PubMed
37301330Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.Pharmacol Ther2023https://conductscience.org/library/papers/37301330PubMed
36765817The Association of Nevus-Associated Melanoma with Common or Dysplastic Melanocytic Nevus: A Systematic Review and Meta-Analysis.Cancers (Basel)2023https://conductscience.org/library/papers/36765817PubMed
36675114Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.Int J Mol Sci2023https://conductscience.org/library/papers/36675114PubMed
36437876CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness.iScience2022https://conductscience.org/library/papers/36437876PubMed
36157497Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance.Genes Dis2022https://conductscience.org/library/papers/36157497PubMed
36119516Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance.Front Oncol2022https://conductscience.org/library/papers/36119516PubMed

See all 190 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6500548

GET https://conductscience.org/api/papers/v1/6500548/cited_by?page=2